About
Roopal Thakkar, M.D., is AbbVie's Executive Vice President, Research & Development and Chief Scientific Officer. He previously served as Senior Vice President of Development and Regulatory Affairs and Chief Medical Officer, and earlier as Vice President, Global Regulatory Affairs and R&D Quality Assurance. Dr. Thakkar joined Abbott in 2003 and was first appointed as an AbbVie corporate officer in December 2023.
Roles
AbbVie Inc.
Executive Vice President, Research & Development and Chief Scientific Officer · Current role
Dec 2023–present
AbbVie
Senior Vice President, Development and Regulatory Affairs and Chief Medical Officer
2022 - 2023
AbbVie
Vice President, Global Regulatory Affairs and R&D Quality Assurance
2019 - 2022
AbbVie
Vice President, Global Regulatory Affairs · Joined Abbott in 2003
2015 - 2019
Fixed Compensation
FY 2025
Change in Pension Value & Nonqualified Deferred Compensation Earnings
$1,416,715
All Other Compensation
$59,767
Performance Compensation
Data from FY 2025
Cash incentive
Annual Cash Incentive (Non-Equity Incentive Plan Compensation)
$2,350,000
Stock awards
Stock Awards (grant-date fair value)
$3,980,457
Option Awards (grant-date fair value)
$959,750